Bayer Stock Surge in 2012 Gives Way to Pfizer Challenge in 2013
Bayer AG (BAYN) will be hard pressed this year to top its world-beating 2012 stock market performance. Analysts predict the stock will be at 72.19 euros in 12 months, based on the average target...
View ArticleBayer CropScience Shares Solutions to Help Growers Achieve an Abundant Tomorrow
Experts on Hand at Commodity Classic Stress Planning, Preparation and Protection to Help Ensure a Successful Growing Season SAN ANTONIO, Feb. 27, 2014 /PRNewswire/ -- Helping growers realize profitable...
View ArticleBayer closes acquisition of consumer care business of Merck & Co., Inc. for...
(Source: Bayer Inc) MCC Acquisition Closing EN FINAL 01-10-2014 News Release Bayer Inc. 77 Belfield Rd. Toronto, ON (416) 248-0771 www.bayer.ca Bayer closes acquisition of consumer care business of...
View ArticleBayer closes acquisition of consumer care business of Merck and Co., Inc.,...
(Source: Bayer plc) Bayer achieves top global positions in key OTC categories; strategic pharma collaboration between Bayer and Merck & Co., Inc. in the field of sGC modulators takes effect Bayer...
View ArticleAnalysis: Bayer immune to pharma's breakup bug?
FRANKFURT (Reuters) - Investors banking on Bayer to embrace a trend in the pharma sector to split off non-core units may be too far ahead of the curve. The diversified German healthcare group has an...
View ArticleBayer: strong growth in Life Sciences (Bayer AG)
(Source: Bayer AG) HealthCare and CropScience post dynamic growth, MaterialScience weak / New pharmaceutical products well above expectations / Group sales rise 1.9 percent (Fx & portfolio adj. 4.6...
View ArticleBayer/Regeneron Continue to Progress with Eylea
Bayer’s (BAYRY) has progressed well with its newly launched products in the last few quarters. Drugs like Eylea (Eye), Stivarga (oncology), Xarelto (anticoagulant), Xofigo (oncology) and Adempas...
View ArticleBayer CropScience steps up investment plans: EUR 2.4 billion earmarked for...
(Source: Bayer AG) Production of key active ingredients to increase substantially / On track to grow sales towards EUR 10 billion in 2015 Monheim, September 5, 2013- Bayer CropScience is on track to...
View ArticleBayer eyes 8 pct annual pharma sales growth through 2016
FRANKFURT, March 12 (Reuters) - German drugmaker Bayer said on Wednesday it aims to increase its...
View ArticleBayer to acquire consumer care business of US-based Merck & Co., Inc. and to...
Move to significantly strengthen position in consumer care -Purchase price of USD 14.2 billion in cash for Merck & Co., Inc.'s consumer care business -Bayer to become the OTC leader in North...
View ArticleBayer to acquire consumer care business of US-based Merck & Co., Inc. and to...
(Source: Bayer Corporation) • Purchase price of USD 14.2 billion in cash for Merck & Co., Inc.'s consumer care business • Bayer to become the OTC leader in North America and Latin America and...
View ArticleBayer Drugs Get Positive CHMP Recommendation
The HealthCare segment at Bayer (BAYRY) received positive nods from the European Committee for Medicinal Products for Human Use (CHMP) for two of its newly launched products for additional indications....
View ArticleBayer Presents Positive Long-Term Results on Adempas
Bayer (BAYRY) announced that positive results from long-term extension studies (CHEST-2 and PATENT-2) on Adempas were presented at the European Respiratory Society (ERS) Congress. These studies are...
View ArticleBayer: Life Sciences off to a good start in anniversary year (Bayer AG)
(Source: Bayer AG) Leverkusen, April 25, 2013 - For the Bayer Group, the first quarter of 2013 was marked by the positive development of its Life Sciences businesses. "HealthCare and CropScience got...
View ArticlePress Forum: “Bayer’s Perspective on Innovation 2014” -- Address by Kemal...
(Source: Bayer AG) (Please check against delivery) (2014-1515e-1) (2014-1515e-2) • Bayer HealthCare Pharmaceuticals is working continuously on the research and development of new therapeutic options...
View ArticleBayer eyes 8 percent annual pharma sales growth through 2016
FRANKFURT (Reuters) - Bayer said newly launched drugs would help shore up the diversified group's pharmaceuticals sales by an average 8 percent per year until 2016, adjusted for currency and portfolio...
View ArticleSecond quarter of 2014: Bayer continues positive business development (Bayer...
(Source: Bayer plc) Leverkusen, July 30, 2014 - The Bayer Group was again successful in the second quarter of 2014. "Our Life Science businesses, in particular, saw unabated growth momentum, with very...
View ArticleSecond quarter of 2014: -- Bayer continues positive business development more...
(Source: Bayer MaterialScience AG) Leverkusen, July 30, 2014 - The Bayer Group was again successful in the second quarter of 2014. "Our Life Science businesses, in particular, saw unabated growth...
View ArticleBayer continues successful course in anniversary year (Bayer AG)
(Source: Bayer AG) Dynamic development in the Life Science businesses, MaterialScience below expectations / Outstanding growth for recently launched pharmaceutical products - estimate of combined peak...
View Article2014 full-year results (Bayer plc)
(Source: Bayer plc) Leverkusen, February 26, 2015 - Bayer had a very successful year in 2014, both operationally and strategically. The company set new records for sales and for EBITDA before special...
View Article
